Louisiana’s abortion drug access law heightens hemorrhage risk for pregnant patients

Louisiana hospitals have faced challenges after a 2024 law reclassified misoprostol as a controlled substance. This drug, crucial for treating hemorrhages, now requires retrieval from a secure location, delaying treatment.